Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease

Digestion

Volumn 63, Issue 3, 2001, Pages 163-170

  Kaspari, S ^a   Biedermann, A ^a   Mey, J ^a  

^a NONE

Author keywords

Gastroesophageal reflux disease; Pantoprazole; Proton pump inhibitor; Ranitidine

Indexed keywords

PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; ADULT; BENZIMIDAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; GERMANY; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; QUALITY OF LIFE; RANITIDINE; SULFOXIDES; TREATMENT OUTCOME;

EID: 0035018757     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051885     Document Type: Article

References (35)

1. Wienheck M, Barnert J: Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol Suppl 1989;156:7-13.
2. Tytgat GN, Nio CY, Schothorgh RH: Reflux esophagitis. Scand J Gastroenterol Suppl 1990; 175:1-12.
3. Green JRB: Is there such an entity as mild oesophagitis? Eur J Clin Res 1993;4:29-34.
4. Revicki DA, Wood M, Maton PN, Sorenson S: Tlie impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998;104:252-258.
5. Wiklund I, Bardhan KD, Muller-Lissner S, Bigard MA, Bianchi-Porro G, Ponce J, Hosie J, Scott M, Weir D, Fulton C, Gillon K, Peacock R: Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine: Results from a multicentre clinical trial. The European Study Group. Ital J Gastroenterol Hepatol 1998;30:19-27.
6. Galmiche JP, Letessier E, Scarpignato C: Treatment of gastro-oesophageal reflux disease in adults. Br Med J 1998;316:1720-1723.
7. Bader JP, Delchier JC: Clinical efficacy of pantoprazole compared with ranitidine. Aliment Pharmacol Ther 1994;8(suppl 1):47-52.
8. Koop H, Schepp W, Dammann HG, Schneider A. Lühmann R, Classen M: Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis: Results of a German multicenter study. J Clin Gastroenterol 1995;20: 192-195.
9. Dammann HG, von Kleist DH: Efficacy and tolerability of pantoprazole versus ranitidine and famotidine in patients with gastro-oesophageal reflux disease: Multicentre, open, randomised, controlled studies; in Domschke W (ed): International Clinical Practice Series. The German pantoprazole phase IV programme. Kent, Wells Medical, 1997, No 15, pp 23-29.
10. van Zyl JH, Grundling H de K, van Rensburg CJ, Retief FJ, O'Keefe SJ, Theron I, Fischer R, Bethke T: Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: A randomized, double-blind, parallel, and multicentre study. Eur J Gastroenterol Hepatol 2000;12:197-202.
11. Dettmer A, Vogt R, Sielaff F, Lühmann R Schneider A, Fischer R: Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis. Aliment Pharmacol Ther 1998;12:865-872.
12. Duvnjak M, Simicevic VN, Supanc V, Troskot B, Pavic T, Hrabar D: Efficacy of pantoprazole in gastroesophageal reflux disease: A comparison with ranitidine. Digestion 1998;59:583.
13. Gallo S, Dihildox M, Moguel A, Di Silvio M, Rodriguez F, Almaguer I, García C, Grupo mexicano de estudio del pantoprazol: Superioridad clinica del pantoprazol sobre la ranitidina en la curación de la esofagitis por reflujo grado II y III: Estudio prospectivo, doble ciego, doble placebo. Experiencia clínica mexicana. Rev Gastroenterol Mex 1998;63:11-16.
14. Ramirez-Barba EJ, Di Silvo M, Dibildox M, Moguel A, Rodriguez F, Almaguer I, Andrade P, Fischer R, Klein M, Wurst W, The Mexican Pantoprazole Study Group in GERD: Superiority of 20 mg pantoprazole vs. 150 mg × 2 ranitidine in healing and symptom relief of patients with mild reflux esophagitis. Gastroenterology 1998;114:G1085.
15. Armbrecht U, Abucar A, Hameeteman W, Schneider A, Stockbrügger RW: Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole: Comparison of 24-hour intragastric and oesophageal pH. Aliment Pharmacol Ther 1997;11:959-965.
16. Dammann HG: Pantoprazole: A pharmacological and clinical profile. Today's Ther Trends 1997;15:109-136.
17. Audigier JC, Marek L, Belin J: An epidemiological investigation in patients with clinical symptoms of gastroesophageal reflux in general medical practice and a pragmatic study on safety and efficacy of pantoprazole in case of oesophagitis, endoscopically proven. Gastroenterology 1998;114:G0248.
18. Bardhan KD, van Rensburg C: Comparison of pantoprazole (PANTO) 20 mg versus omeprazole (OME) 20 mg in patients with mild gastroesophageal reflux disease. Gastroenterology 1999;116:G0510.
19. Moola SAH, van Rensburg CJ, Kassianides C, Pretorius CF, van Zyl JH, Schutte L, Theron I, Schneider A, Heinze H, Lühmann R: Efficacy of pantoprazole 20 mg vs. placebo once daily in the treatment of patients with symptomatic reflux disease and endoscopically normal esophagus. Gastroenterology 1999;116: G0785.
20. Savary M, Miller G: Das Oesophagus-Lehrbuch und endoskopischer Atlas. Solothurn, Gassmann, 1977.
21. 13C-urea breath test. Lancet 1987;i:1174-1177.
22. Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H: Gastrointestinal Quality of Life Index: Development, validation and application of a new instrument. Br J Surg 1995;82:216-222.
23. Bullinger M: German translation and psychometric testing of the SF-36 Health Survey: Preliminary results from the IQOLA Project. International Quality of Life Assessment. Soc Sci Med 1995;41:1359-1366.
24. Blackwelder WC: 'Proving the null hypothesis' in clinical trials. Controlled Clin Trials 1982;3: 345-353.
25. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH: Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis. Gastroenterology 1997;112: 1798-1810.
26. Fitton A, Wiseman L: Pantoprazole: A review of its pharmacological properties and therapeutic use in acid related disorders. Drugs 1996;51:460-482.
27. Garner A, Fadlallah H: Pantoprazole: A new and more specific proton pump inhibitor. Exp Opin Invest Drugs 1997;6:885-893.
28. Bardhan KD: Pantoprazole: A new proton pump inhibitor in the management of upper gastrointestinal disease. Drugs Today 1999;35: 773-808.
29. Dent J, Watts R, Riley S, Scheikh R, de Groot G, van Oudvorst A, Hatlebakk J, Haug K, Carlsson R, Dalväg A, Junghard O, Wiklund I: Omeprazole improves quality of life in patients with gastroesophageal reflux disease. Gastroenterology 1996;110:A94.
30. Lind T, Havelund T, Glise H, Hernqvist H, Lauritsen K, Lundell L, Pedersen SA, Wiklund I: Omeprazole improves quality of life in patients with endoscopy negative reflux disease. Gastroenterology 1995;108:A151.
31. Holtmann G, Cain CR, Malfertheiner P: Gastric H. pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 1999;117:11-16.
32. Pace F, Blanchi Porro G: Gastro-oesophageal reflux and Helicobacter pylori. Ital J Gastroenterol Hepatol 1998;30(suppl 3):S289-S293.
33. O'Connor HJ: Review article: Helicobacter pylori and gastro-oesophageal reflux disease. Clinical implications and management. Aliment Pharmacol Ther 1999;13:117-127.
34. Lahenz J, Meining A, Tillenburg B, Stolte M: Helicobacteriose: Update 1999. Leber Magen Darm 1999;29:80-92.
35. Bochenek W, Miska D, Beg M: Efficacy of pantoprazole in reflux erosive esophagitis is dose related. Digestion 1998:59(suppl 3):601.